Ovarian cancer treatment: The end of empiricism?

Por Lheureux, Stephanie, Karakasis, Katherine, Kohn, Elise C., Oza, Amit M.
Publicado no Cancer (2015)

Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention

Por Karakasis, Katherine, Burnier, Julia V., Bowering, Valerie, Oza, Amit M., Lheureux, Stephanie
Publicado no Front Oncol (2016)

The motivations and methodology for high-throughput PET imaging of small animals in cancer research

Por Aide, Nicolas, Visser, Eric P., Lheureux, Stéphanie, Heutte, Natacha, Szanda, Istvan, Hicks, Rodney J.
Publicado em 2012

(18)F-FDG Is a Surrogate Marker of Therapy Response and Tumor Recovery after Drug Withdrawal during Treatment with a Dual PI3K/mTOR Inhibitor in a Preclinical Model of Cisplatin-Re...

Por Lheureux, Stéphanie, Lecerf, Charlotte, Briand, Mélanie, Louis, Marie-Hélène, Dutoit, Soizic, Jebahi, Abdelghani, Giffard, Florence, Fournier, Cécile Blanc, Batalla, Alain, Poulain, Laurent, Aide, Nicolas
Publicado em 2013